At the Napa Valley Cardiology Conference, cardiac electrophysiologists Dr. Thomas Deering of Piedmont Heart and Dr. Paul Wang of Stanford talk about stroke reduction in atrial fibrillation. From new anticoagulation agents to a recently FDA–approved percutaneous device, major advances in the field are providing effective treatment options for patients.